Q&A

What does the recent FDA clearance of this treatment for adolescents mean for the future of MDD treatment?

What are the most effective approaches to SUD treatment in this unique patient population?

Rosine Perelberg, PhD, discusses psychoanalytic thought, social anthropology, and the future of psychoanalysis.

Rejoyn was recently cleared by the FDA, making it the first prescription digital therapeutic for major depressive disorder.

Join us in congratulating Dr Tampi on his recent win of the American Association for Geriatric Psychiatry’s Diversity Award!

Elena Koundourakis, the head of the Orexin Franchise Development and Portfolio Strategy at Takeda, shares her thoughts on the recent positive topline results from a phase 2 trial evaluating TAK-861, an oral orexin receptor 2 agonist, in patients with narcolepsy type 1.

Learn more about the inaugural Black Youth Mental Health Clinical Case Conference Series at Yale Child Study Center, a 6-session event in 2024, that focuses on improving mental health care for Black youth and their families.

Frank Clark, MD, the Psychiatric Times Diversity & Inclusion Section Editor, was recently appointed president of The Greenville County Medical Society, the first Black doctor to serve in this role.

“Freudian thought has massively influenced not only modern understandings of mind and therapeutic treatment, but also modernism and many distinct visions of politics.”

These important findings on esketamine nasal spray as a treatment for young individuals with suicidal ideation were presented at the ACNP 2023 Annual Meeting. We interviewed the vice president and head of neuropsychiatry clinical development at Johnson & Johnson Innovative Medicine to learn more.

Just because a patient has anxiety or past trauma does not mean they cannot enjoy this spooky holiday…

The senior vice president of research at the American Foundation for Suicide Prevention offers thoughts on suicide and students.

A recent survey found mental health and finances were some of the top stressors for college students.

The 988 Implementation Act was introduced on July 25. What impact will it have on care?

One professional psychiatrist shares his account of living with bipolar affective disorder.

A phase 2A trial recently received confirmation to proceed in investigating psilocybin-assisted psychotherapy in the treatment of adult patients with IBS.

Learn more about a comprehensive system of care for those who are in crisis and need immediate access to care, aided by the new 988 Suicide & Crisis Lifeline.

What is it like to be a 988 counselor?

We connected with a group working on the frontlines of Southern Turkey and Northern Syria to assist the survivors of the devastating earthquake.

Celebrating 25 years of Poetry of the Times with Richard Berlin, MD!

How can you better provide care for American Indians and Alaska Natives?

“My ideal for the book was a kind of prism: If you look at the same questions from different angles, the answers will subtly change.”

A new poll sought to understand the public’s beliefs about mental health and suicide prevention. Here are the results.

Suicide Prevention Week is September 4-10. Are you ready?

This new study is evaluating how effective psychedelics can be in the treatment of binge eating disorder.

The American Foundation for Suicide Prevention collaborates with Most Days, a mental health app, to provide suicide prevention expertise and content. Learn more about the partnership here.

Is the mental health of young athletes in danger?

TikTok: How is it harming child and adolescent mental health?

The Chief Medical Officer for the AFSP sat down with Psychiatric Times to talk about the new Blueprint for Youth Suicide Prevention.

TikTok has over 1 billion users and dominates youth culture. But is it damaging their mental health?